<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730603</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Identification of potential susceptibility genes in patients with primary Sj&#xf6;gren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.</ArticleTitle><Pagination><StartPage>175</StartPage><MedlinePgn>175</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-023-03171-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary arterial hypertension (PAH) is a rare complication of primary Sj&#xf6;gren's syndrome (pSS). Several genes have proven to be associated with pSS and PAH. However, there is no study specifically addressing the genetic susceptibility in pSS combined with PAH.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-four unrelated patients with pSS-PAH were recruited from April 2019 to July 2021 at Peking Union Medical College Hospital. Demographic and clinical data were recorded in detail, and peripheral blood samples were collected for whole-exome sequencing (WES). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to predict the functional effect of mutant genes. Genetic variants identified by WES were confirmed by polymerase chain reaction (PCR)-Sanger sequencing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We totally identified 141 pathogenic variant loci of 129 genes in these 34 pSS-PAH patients, using WES analysis. Patients with a family history of rheumatic diseases are more likely to carry FLG mutations or carry gene variations related to the biosynthesis of the amino acids pathway (p&#x2009;&lt;&#x2009;0.05). According to Sanger sequencing confirmation and pathogenicity validation, we totally identified five candidate pathogenic variants including FLG c.12064A&#x2009;&gt;&#x2009;T, BCR c.3275_3278dupCCGG, GIGYF2 c.3463C&#x2009;&gt;&#x2009;A, ITK c.1741C&#x2009;&gt;&#x2009;T, and SLC26A4 c.919-2A&#x2009;&gt;&#x2009;G.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings provide preliminary data of exome sequencing to identify susceptibility loci for pSS-PAH and enriched our understanding of the genetic etiology for pSS-PAH. The candidate pathogenic genes may be the potential genetic markers for early warning of this disease.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Mucong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Institute of Basic Medical Sciences &amp; Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Chinese Rheumatism Data Center (CRDC), Chinese SLE Treatment and Research Group (CSTAR), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Institute of Basic Medical Sciences &amp; Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Chinese Rheumatism Data Center (CRDC), Chinese SLE Treatment and Research Group (CSTAR), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jiuliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Chinese Rheumatism Data Center (CRDC), Chinese SLE Treatment and Research Group (CSTAR), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Chinese Rheumatism Data Center (CRDC), Chinese SLE Treatment and Research Group (CSTAR), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengtao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Chinese Rheumatism Data Center (CRDC), Chinese SLE Treatment and Research Group (CSTAR), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. mengtao.li@cstar.org.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Institute of Basic Medical Sciences &amp; Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China. xiulizhao@ibms.pumc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202010023025</GrantID><Agency>National College Students' innovation training program</Agency><Country/></Grant><Grant><GrantID>2021-I2M-1-005</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-013</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BCR</Keyword><Keyword MajorTopicYN="N">FLG</Keyword><Keyword MajorTopicYN="N">GIGYF2</Keyword><Keyword MajorTopicYN="N">ITK</Keyword><Keyword MajorTopicYN="N">Primary Sj&#xf6;gren&#x2019;s syndrome</Keyword><Keyword MajorTopicYN="N">Pulmonary arterial hypertension</Keyword><Keyword MajorTopicYN="N">SLC26A4</Keyword><Keyword MajorTopicYN="N">Whole-exome sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730603</ArticleId><ArticleId IdType="doi">10.1186/s13075-023-03171-y</ArticleId><ArticleId IdType="pii">10.1186/s13075-023-03171-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fox RI. Sj&#xf6;gren&#x2019;s syndrome. Lancet. 2005;366(9482):321&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16039337</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(05)66990-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, et al. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Int J Cardiol. 2017;236:432&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28159359</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2017.01.097</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">24355639</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2013.10.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li M, Wang Q, Zhang X, Qian J, Zhao J, et al. Pulmonary arterial hypertension associated with primary Sj&#xf6;gren&#x2019;s syndrome: a multicentre cohort study from China. Eur Respir J. 2020;56(5):1902157.</Citation><ArticleIdList><ArticleId IdType="pubmed">32616590</ArticleId><ArticleId IdType="doi">10.1183/13993003.02157-2019</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JD, Girerd B, Montani D, Wang XJ, Gali&#xe8; N, Austin ED, et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med. 2016;4(2):129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">26795434</ArticleId><ArticleId IdType="pmc">4737700</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(15)00544-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XJ, Lian TY, Jiang X, Liu SF, Li SQ, Jiang R, et al. Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension. Eur Respir J. 2019;53(3):1801609.</Citation><ArticleIdList><ArticleId IdType="pubmed">30578397</ArticleId><ArticleId IdType="doi">10.1183/13993003.01609-2018</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XJ, Xu XQ, Sun K, Liu KQ, Li SQ, Jiang X, et al. Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension. JAMA Cardiol. 2020;5(6):677&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">32236489</ArticleId><ArticleId IdType="doi">10.1001/jamacardio.2020.0479</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yang J, Li MT, Wang Q, Zhao JL, Yang XX, et al. CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus. Chin Med J (Engl). 2018;131(24):3020&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">30539924</ArticleId><ArticleId IdType="doi">10.4103/0366-6999.247212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Gonzalez I, Tenorio-Castano J, Ochoa-Parra N, Gallego N, P&#xe9;rez-Olivares C, Lago-Docampo M, et al. Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease. Cells. 2021;10(6):1488.</Citation><ArticleIdList><ArticleId IdType="pubmed">34199176</ArticleId><ArticleId IdType="pmc">8231632</ArticleId><ArticleId IdType="doi">10.3390/cells10061488</ArticleId></ArticleIdList></Reference><Reference><Citation>Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sjogren's syndrome. Rheumatology (Oxford). 2019.</Citation></Reference><Reference><Citation>Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj&#xf6;gren&#x2019;s syndrome at 7q11.23. Nature Genetics. 2013;45:1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">24097066</ArticleId><ArticleId IdType="doi">10.1038/ng.2779</ArticleId></ArticleIdList></Reference><Reference><Citation>Reksten TR, Johnsen SJ, Jonsson MV, Omdal R, Brun JG, Theander E, et al. Genetic associations to germinal centre formation in primary Sjogren&#x2019;s syndrome. Ann Rheum Dis. 2014;73(6):1253&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23606706</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2012-202500</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj&#xf6;gren&#x2019;s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006334</ArticleId><ArticleId IdType="pmc">1754137</ArticleId><ArticleId IdType="doi">10.1136/ard.61.6.554</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sj&#xf6;gren&#x2019;s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69(1):35&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">27785888</ArticleId><ArticleId IdType="doi">10.1002/art.39859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gali&#xe8; N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">26320113</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehv317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sj&#xf6;gren&#x2019;s Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sj&#xf6;gren&#x2019;s syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007;56(7):2223&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17599741</ArticleId><ArticleId IdType="doi">10.1002/art.22658</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">3344216</ArticleId><ArticleId IdType="pmc">334765</ArticleId><ArticleId IdType="doi">10.1093/nar/16.3.1215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Zhao S, Yu C, Wu D, Yan Z, Fan L, et al. Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature. J Genet Genomics. 2021;48(5):396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">34006472</ArticleId><ArticleId IdType="doi">10.1016/j.jgg.2021.02.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6(12):e1001025.</Citation><ArticleIdList><ArticleId IdType="pubmed">21152010</ArticleId><ArticleId IdType="pmc">2996323</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1001025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircher M, Witten DM, Jain P, O&#x2019;Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24487276</ArticleId><ArticleId IdType="pmc">3992975</ArticleId><ArticleId IdType="doi">10.1038/ng.2892</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc. 2016;11(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26633127</ArticleId><ArticleId IdType="doi">10.1038/nprot.2015.123</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20354512</ArticleId><ArticleId IdType="pmc">2855889</ArticleId><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WHI, Shimizu H. FLG mutation p.Lys4021X in the C-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. Br J Dermatol. 2009;161(6):1387&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">19663875</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2133.2009.09406.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Xiong Z, Xu X, Li F, Lu L, Li W, et al. Loss-of-function mutations in filaggrin gene associate with psoriasis vulgaris in Chinese population. Hum Genet. 2012;131(7):1269&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">22407025</ArticleId><ArticleId IdType="doi">10.1007/s00439-012-1155-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghani M, Lang AE, Zinman L, Nacmias B, Sorbi S, Bessi V, et al. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol Aging. 2015;36(1):545.e9-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25174650</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.038</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinVar. NM_005546.4(ITK):c.1741C&gt;T (p.Arg581Trp) AND Lymphoproliferative syndrome 1. https://www.ncbi.nlm.nih.gov/clinvar/134372508/ .</Citation></Reference><Reference><Citation>ClinVar. NM_005546.4(ITK):c.1741C&gt;T (p.Arg581Trp) AND Autoinflammatory syndrome. https://www.ncbi.nlm.nih.gov/clinvar/134695889/ .</Citation></Reference><Reference><Citation>Hassoun PM. Pulmonary Arterial Hypertension. N Engl J Med. 2021;385(25):2361&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">34910865</ArticleId><ArticleId IdType="doi">10.1056/NEJMra2000348</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumakis E, Wipff J, Dieud&#xe9; P, Ruiz B, Bouaziz M, Revillod L, et al. TGF&#x3b2; receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients. Ann Rheum Dis. 2012;71(11):1900&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22896741</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2012-201755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Drexler I, Bhatia S, Adler H, Gennery AR, Borkhardt A. Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight? Front Immunol. 2018;9:979.</Citation><ArticleIdList><ArticleId IdType="pubmed">29867957</ArticleId><ArticleId IdType="pmc">5951928</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.00979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen S, Chen J, Xie X, Gao S, Zhang C, et al. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj&#xf6;gren&#x2019;s syndrome highlight T cell-initiated autoimmunity. Ann Rheum Dis. 2020;79(2):268&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">31848144</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2019-215533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadeem A, Al-Harbi NO, Ahmad SF, Al-Harbi MM, Alhamed AS, Alfardan AS, et al. Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress. Int Immunopharmacol. 2020;83:106369.</Citation><ArticleIdList><ArticleId IdType="pubmed">32163900</ArticleId><ArticleId IdType="doi">10.1016/j.intimp.2020.106369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagiv-Barfi I, Kohrt HE, Czerwinski DK, Ng PP, Chang BY, Levy R. Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. Proc Natl Acad Sci U S A. 2015;112(9):E966&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25730880</ArticleId><ArticleId IdType="pmc">4352777</ArticleId><ArticleId IdType="doi">10.1073/pnas.1500712112</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Liu Z, Gan Y, Gao X, Zu X, Zhang Y, et al. SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer. J Transl Med. 2022;20(1):313.</Citation><ArticleIdList><ArticleId IdType="pubmed">35836192</ArticleId><ArticleId IdType="pmc">9281181</ArticleId><ArticleId IdType="doi">10.1186/s12967-022-03513-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing M, Tokumaru Y, Wu G, Westra WB, Ladenson PW, Sidransky D. Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res. 2003;63(9):2312&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12727855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroeger H, Jelinek J, Est&#xe9;cio MR, He R, Kondo K, Chung W, et al. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood. 2008;112(4):1366&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18523155</ArticleId><ArticleId IdType="pmc">2515110</ArticleId><ArticleId IdType="doi">10.1182/blood-2007-11-126227</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Li J, Hu X, Ye J, Cai W. SLC26A4 Mutation Promotes Cell Apoptosis by Inducing Pendrin Transfer, Reducing Cl(-) Transport, and Inhibiting PI3K/Akt/mTOR Pathway. Biomed Res Int. 2022;2022:6496799.</Citation><ArticleIdList><ArticleId IdType="pubmed">36072472</ArticleId><ArticleId IdType="pmc">9444440</ArticleId><ArticleId IdType="doi">10.1155/2022/6496799</ArticleId></ArticleIdList></Reference><Reference><Citation>Babicheva A, Makino A, Yuan JX. mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. Int J Mol Sci. 2021;22(4):2144.</Citation><ArticleIdList><ArticleId IdType="pubmed">33670032</ArticleId><ArticleId IdType="pmc">7926633</ArticleId><ArticleId IdType="doi">10.3390/ijms22042144</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman AEG, Deininger MW. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions. Blood Rev. 2021;49:100825.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773846</ArticleId><ArticleId IdType="pmc">8563059</ArticleId><ArticleId IdType="doi">10.1016/j.blre.2021.100825</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenholz I, Kerscher T, Bauerfeind A, Esparza-Gordillo J, Nickel R, Keil T, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol. 2009;123(4):911&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19348926</ArticleId><ArticleId IdType="doi">10.1016/j.jaci.2009.01.051</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudot T, Lesueur F, Guedj M, de Cid R, McGinn S, Heath S, et al. An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders. J Invest Dermatol. 2009;129(11):2637&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">19554025</ArticleId><ArticleId IdType="doi">10.1038/jid.2009.157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross KA. Coherent somatic mutation in autoimmune disease. PLoS One. 2014;9(7):e101093.</Citation><ArticleIdList><ArticleId IdType="pubmed">24988487</ArticleId><ArticleId IdType="pmc">4079513</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0101093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautier C, Goldwurm S, D&#xfc;rr A, Giovannone B, Tsiaras WG, Pezzoli G, et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am J Hum Genet. 2008;82(4):822&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">18358451</ArticleId><ArticleId IdType="pmc">2427211</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2008.01.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S, Iseki E, Minegishi M, Togo T, Kabuta T, Wada K. GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation. J Neurochem. 2010;115(2):423&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">20670374</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06930.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>